Research Article
Comparison of the Freiburg and Charlson Comorbidity Indices in Predicting Overall Survival in Elderly Patients with Newly Diagnosed Multiple Myeloma
Table 5
Serious adverse events (AEs).
| | | (%) | | | Grade 0–3 | Grade 4-5 |
| | Hematologic AE | | | | Anemia | 103 (87.3%) | 15 (12.7%) | | Neutropenia | 103 (87.3%) | 15 (12.7%) | | Thrombocytopenia | 114 (92.2%) | 4 (7.8%) | | Febrile neutropenia | 113 (90.8%) | 5 (9.2%) |
| | | Grade 0–2 | Grade 3–5 |
| | Nonhematologic AE | | | | Infection | 83 (70.0%) | 35 (30.0%) | | Diarrhea/constipation | 105 (89.0%) | 13 (11.0%) | | Fatigue | 117 (90.7%) | 11 (9.3%) | | Sensory neuropathy | 108 (91.5%) | 10 (8.5%) | | Nausea/vomiting | 111 (94.1%) | 7 (5.9%) | | Azotemia | 112 (94.9%) | 6 (5.1%) |
| | Grade ≥4 hematologic AE | 27 (22.9%) | | Grade ≥3 nonhematologic AE | 59 (50.0%) | | Grade 5 AE | 8 (6.8%) |
|
|
